QTTB

NASD Q32 Bio Inc
Sep 30, 2026 · 6:58 AM ET LAST TRADE Market Closed

$10.56 ↑ +1.03 (+10.81%) Trading Up from the previous close of $9.53

YTD change
+218.07%
vs 20-day SMA
-3.65%
vs 200-day SMA
+22.12%

Price ranges

Previous day
$9.16 $9.67
open $9.32 close $9.53
+$0.21 (+2.25%)
Today
$0.00 $0.00
$10.56
Past week
$8.74 $10.58
from $10.57 now $10.56
-$0.01 (-0.09%)
Past month
$8.74 $14.87
from $14.87 now $10.56
-$4.31 (-28.98%)
This year
$3.19 $23.57
from $3.32 now $10.56
+$7.24 (+218.07%)

Price & Performance

+3.63 (+61.53%) / 6M

$3.60$9.97$16.33$22.70Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 80.4% away from all-time highs of $53.79
  • QTTB is up 218% since the beginning of the year
  • QTTB is up 433% over the past 12 months
  • QTTB is down 29% over the past 1 month
  • 13% of all QTTB investors are betting against QTTB

QTTB reads neutral: price sits above one of the two key moving averages, the 12-month move is +381.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.44
Earnings momentum -33.3% Quarterly EPS growth
Quarterly change -33.3%

Valuation

P/E ratio 2.80
Enterprise value $92.9M
Beta -0.62

Balance sheet & scale

Income$33.8K
Revenue$53.7M
Cash$106.3M
Debt$5.3K
Income / Debt 6.38×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $367.5M

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David S. Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.